Featured Question
A 42-year-old male presents with resectable RCC and is expected to be "disease-free" after nephrectomy. Is there a role for targeted agents before or after surgery?
Get the latest
science delivered
to your inbox
Answers in CME updates are
available in YOUR specialty.
05-14-2013
Targeting the Kidney in Type 2 Diabetes: Rationale for Novel Treatment Approaches
Course Director
Vivian Fonseca, MD
Tulane University Health Sciences Center
New Orleans, Louisiana
04-03-2013
Selecting Appropriate Therapy for HER2‐Positive Breast Cancer
Course Director
Kimberly L. Blackwell, MD
Professor of Medicine
Assistant Professor of Radiation Oncology
Director, Breast Cancer Program
Duke Cancer Institute
Durham, North Carolina
03-15-2013
Challenging Cases in Multiple Sclerosis
Course Director
Aaron E. Miller, MD
Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Mount Sinai School of Medicine
New York, New York
02-15-2013
Updates in Multiple Sclerosis: Implications of the Latest Data for Practice
Course Director
Aaron E. Miller, MD
Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Mount Sinai School of Medicine
New York, New York
11-30-2012
Q&A: Improving Outcomes in Rheumatoid Arthritis
Course Director
Yusuf Yazici, MD
Assistant Professor
New York University School
of Medicine
NYU Hospital for Joint Diseases
New York, New York
10-22-2012
Q&A: Better Practices, Better Outcomes in Acute Stroke and Parkinson’s Disease
Course Directors
Michael F. Waters, MD, PhD
Director of the Stroke Program
Department of Neurology
University of Florida & Shands Hospital
Gainesville, Florida
Ramon L. Rodriguez, MD
Associate Professor of Neurology
UF Center for Movement Disorders and Neurorestoration
University of Florida College
of Medicine
Gainesville, Florida
10-05-2012
Advances in the Management of Serious Infection Due to MRSA
Course Director
Loren G. Miller, MD, MPH
Associate Professor of Medicine
David Geffen School of Medicine at UCLA
Division of Infectious Diseases
Director, Infection Prevention and Control Program
Harbor-UCLA Medical Center
Torrance, California
09-28-2012
Targeted Therapy for RA: Q&A on Individualizing Treatment
Course Director
Allan Gibofsky, MD
Professor of Medicine and Public Health
Weill Cornell Medical College
Attending Rheumatologist
Hospital for Special Surgery
New York, New York
09-12-2012
Expert Perspectives in Advanced Prostate Cancer
Course Director
Oliver Sartor, MD
Medical Director, Tulane Cancer Center
C.E. and Bernadine Laborde Professor of Cancer Research
Professor, Department of Medicine Section of Hematology & Medical Oncology
Department of Urology
Tulane University School of Medicine
New Orleans, Louisiana
09-05-2012
Improving Outcomes in Invasive Fungal Infections
Course Director
Luis Ostrosky-Zeichner, MD, FACP, FIDSA
Professor of Medicine and Epidemiology
Division of Infectious Diseases
University of Texas
Medical School at Houston
Medical Director for Epidemiology
Memorial Hermann
Texas Medical Center
Houston, Texas